XML 18 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]    
Revenues $ 76,427 $ 66,494
Cost of products sold 53,111 47,144
Gross profit 23,316 19,350
Operating expenses:    
Research and defelopment 5,603 5,333
Selling, general and administrative 14,233 15,460
Intangible asset impairment 150 0
Total operating expenses 19,986 20,793
Operating income (loss) 3,330 (1,443)
Other (expense) income:    
Interest income 3 13
Interest and financing expense (248) (218)
Miscellaneous 65 (154)
Income (loss) from continuing operations before income taxes 3,150 (1,802)
Income tax provision 310 268
Net income (loss) from continuing operations 2,840 (2,070)
(Loss) from discontinued operations, net of tax 0 61
Net income (loss) 2,840 (2,131)
Net loss attributable to noncontrolling interest 29 15
Net income (loss) attributable to Ultralife 2,869 (2,116)
Other comprehensive income - Foreign currency translation adjustments (440) 147
Comprehensive loss attributable to Ultralife $ 2,429 $ (1,969)
Net income (loss) per share attributable to Ultralife common shareholders - basic: (in dollars per share):    
Continuing operations $ .18 $ (0.12)
Discontinued operations 0 0
Total .18 (0.12)
Net income (loss) per share attributable to Ultralife common shareholders - diluted: (in dollars per share):    
Continuing operations .17 (.12)
Discontinued operations $ 0 $ 0
Weighted average shares outstanding - basic 16,182,000 17,475,000
Weighted average shares outstanding - diluted 16,458,000 17,475,000